Strategic Brand Reuse Propeller Health operates under the Resmed umbrella with retained brand, IP, and assets after cessation of Propeller’s operations. Sales opportunities exist in leveraging Resmed’s broader sleep and respiratory health ecosystem to cross-sell Propeller's digital health capabilities to existing Resmed customers and partners.

Capital & Investment Momentum Recent Series C funding of 21.5M led by 3M Ventures signals investor confidence and potential for scaled deployment. Business development can target ventures and payers in respiratory care, leveraging the funding to secure co-development or procurement contracts with health systems and pharmaceutical partners.

Enterprise Partnerships Propeller has a history of collaborations with health systems, DOHC, and Novartis, including co-packaging digital health platforms and distribution in new markets. Opportunities exist to re-engage pharma and health system accounts for inhaler adherence, COPD/asthma management programs, and value-based care initiatives.

Technology Stack Fit The tech stack includes cloud services, analytics, CRM and marketing platforms, enabling integration with EHRs and enterprise data workflows. Sales plays can emphasize seamless data integration, population health analytics, and scalable platform deployment for large health systems and payers.

Market Traction Signals Awards, acquisitions, and strategic partnerships indicate proven clinical impact and market interest in digital health for respiratory conditions. Position Propeller as a scalable solution for reducing exacerbations, improving adherence, and lowering costs, aligning with payer and provider ROI priorities.